Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. In our 2024-25 Innovation Seed Grant competition, the Centre funded...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
3D models of heart failure… stiffened hearts in diabetes…. saving infant lives
After a heart attack, this peptide protects the heart from further injury
Featured Event
Heart Failure Symposium 2025
Virtual Library
Visit our YouTube channel filled with world-class heart failure educational sessions on diverse topics
XVIIIth International Symposium on Atherosclerosis
June 9, 2018 - June 12, 2018
The ISA 2018 Symposium will be focused on cutting-edge research in the areas of atherosclerosis, thrombosis and vascular biology and will feature:
4-day program attracting 1500+ international professionals, organized in collaboration with opinion-leaders in atherosclerosis research from across the globe;
5 exciting program tracks including: Dyslipidemia, Epidemiology, Pathogenesis, Prevention and Therapeutics;
100+ internationally recognized speakers, leading plenary and parallel scientific sessions in basic, clinical and public health science of atherosclerosis; Global innovation and public health awareness forums;
Pre- and post-meeting satellite symposia;
Ground-breaking abstracts and scientific posters;
Networking and collaboration hubs;
Industry-sponsored social events, receptions, symposia, and faculty events;